4th Quarter - Report

HUMANA, INC. for HUMANA INC

Firm
Client
Income
—
Expenses
$1,270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues

LobbyistCovered position, as disclosed
TIFFANY HAVERLY —
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Medicare Advantage (MA) Policy and Reimbursement Enactment of policies in Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Calendar Year (CY) 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F) Medicare Prescription Payment Plan: Final Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, and Response to Relevant Comments Medicare Prescription Payment Plan Final Part Two Guidance Implementation of CMS Interoperability and Prior Authorization final rule (CMS-0057-F) Calendar Year (CY) 2025 Home Health Prospective Payment System Final Rule (CMS-1803-F) Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F) Announcement of Calendar Year 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Final Calendar Year (CY) 2025 Part D Redesign Program Instructions Fiscal Year (FY) 2025 Hospice Payment Rate Update Final Rule (CMS-1810-F) CY 2025 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule (CMS 1809-FC) Calendar Year (CY) 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-P)

LobbyistCovered position, as disclosed
TIFFANY HAVERLY —
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office

Bills named: H.R. 8702 (118th), S. 4532 (118th)

Defense DEF

TRICARE Policy Issues including Telehealth, Value-Based Care, and T-5 Transition NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues H.R. 5009, The Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025

LobbyistCovered position, as disclosed
TIFFANY HAVERLY —
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE

Bills named: H.R. 5009 (118th)

Taxation/Internal Revenue Code TAX

Tax Reform Implementation Issues

LobbyistCovered position, as disclosed
TIFFANY HAVERLY —
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.